These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 31436118)

  • 1. Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery.
    Nocentini A; Supuran CT
    Expert Opin Drug Discov; 2019 Nov; 14(11):1175-1197. PubMed ID: 31436118
    [No Abstract]   [Full Text] [Related]  

  • 2. Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery.
    Supuran CT
    Expert Opin Drug Discov; 2020 Jun; 15(6):671-686. PubMed ID: 32208982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in structure-based drug discovery of carbonic anhydrase inhibitors.
    Supuran CT
    Expert Opin Drug Discov; 2017 Jan; 12(1):61-88. PubMed ID: 27783541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How many carbonic anhydrase inhibition mechanisms exist?
    Supuran CT
    J Enzyme Inhib Med Chem; 2016; 31(3):345-60. PubMed ID: 26619898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the discovery of zinc-binding motifs for the development of carbonic anhydrase inhibitors.
    Winum JY; Supuran CT
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):321-4. PubMed ID: 24939097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase.
    Nocentini A; Angeli A; Carta F; Winum JY; Zalubovskis R; Carradori S; Capasso C; Donald WA; Supuran CT
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):561-580. PubMed ID: 33615947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases.
    Pinard MA; Boone CD; Rife BD; Supuran CT; McKenna R
    Bioorg Med Chem; 2013 Nov; 21(22):7210-5. PubMed ID: 24090602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase inhibitors drug design.
    McKenna R; Supuran CT
    Subcell Biochem; 2014; 75():291-323. PubMed ID: 24146385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors.
    De Simone G; Alterio V; Supuran CT
    Expert Opin Drug Discov; 2013 Jul; 8(7):793-810. PubMed ID: 23627619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based drug discovery of carbonic anhydrase inhibitors.
    Supuran CT
    J Enzyme Inhib Med Chem; 2012 Dec; 27(6):759-72. PubMed ID: 22468747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008-2018).
    Nocentini A; Supuran CT
    Expert Opin Ther Pat; 2018 Oct; 28(10):729-740. PubMed ID: 30074415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing of novel carbonic anhydrase inhibitors and activators.
    Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):49-68. PubMed ID: 15328829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of two-tail compounds with rotationally fixed benzenesulfonamide ring as inhibitors of carbonic anhydrases.
    Zakšauskas A; Čapkauskaitė E; Jezepčikas L; Linkuvienė V; Kišonaitė M; Smirnov A; Manakova E; Gražulis S; Matulis D
    Eur J Med Chem; 2018 Aug; 156():61-78. PubMed ID: 30006175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxamate represents a versatile zinc binding group for the development of new carbonic anhydrase inhibitors.
    Di Fiore A; Maresca A; Supuran CT; De Simone G
    Chem Commun (Camb); 2012 Sep; 48(70):8838-40. PubMed ID: 22836518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects.
    Pastorekova S; Parkkila S; Pastorek J; Supuran CT
    J Enzyme Inhib Med Chem; 2004 Jun; 19(3):199-229. PubMed ID: 15499993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The coumarin-binding site in carbonic anhydrase accommodates structurally diverse inhibitors: the antiepileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors.
    Temperini C; Innocenti A; Scozzafava A; Parkkila S; Supuran CT
    J Med Chem; 2010 Jan; 53(2):850-4. PubMed ID: 20028100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonic anhydrase inhibitors: a review on the progress of patent literature (2011-2016).
    Lomelino C; McKenna R
    Expert Opin Ther Pat; 2016 Aug; 26(8):947-56. PubMed ID: 27387065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Bacterial Carbonic Anhydrases as a Novel Approach to Escape Drug Resistance.
    Capasso C; Supuran CT
    Curr Top Med Chem; 2017; 17(11):1237-1248. PubMed ID: 28049405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies.
    Bozdag M; Ferraroni M; Nuti E; Vullo D; Rossello A; Carta F; Scozzafava A; Supuran CT
    Bioorg Med Chem; 2014 Jan; 22(1):334-40. PubMed ID: 24300919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Classical Inhibition of Carbonic Anhydrase.
    Lomelino CL; Supuran CT; McKenna R
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27438828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.